Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Additive interactions can have public health and etiological implications but are infrequently reported. We assessed departures from additivity on the absolute risk scale between 9 established breast cancer risk factors and 23 susceptibility single-nucleotide polymorphisms (SNPs) identified from gen...

Полное описание

Библиографические подробности
Главные авторы:	Joshi, A, Lindström, S, Hüsing, A, Barrdahl, M, VanderWeele, T, Campa, D, Canzian, F, Gaudet, M, Figueroa, J, Baglietto, L, Berg, C, Buring, J, Chanock, S, Chirlaque, MD, Diver, W, Dossus, L, Giles, G, Haiman, C, Hankinson, SE, Henderson, B, Hoover, R, Hunter, D, Isaacs, C, Kaaks, R, Kolonel, L
Формат:	Journal article
Язык:	English
Опубликовано:	Oxford University Press 2014

Схожие документы

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
по: Campa, D, и др.
Опубликовано: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
по: Campa, D, и др.
Опубликовано: (2011)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
по: Barrdahl, M, и др.
Опубликовано: (2014)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Cox, D, и др.
Опубликовано: (2006)

Haplotypes of the estrogen receptor beta gene and breast cancer risk.
по: Cox, D, и др.
Опубликовано: (2008)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
по: Campa, D, и др.
Опубликовано: (2012)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
по: Schumacher, F, и др.
Опубликовано: (2007)

A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.
по: Daniele Campa, и др.
Опубликовано: (2014-01-01)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Patel, A, и др.
Опубликовано: (2008)

Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
по: Daniele Campa, и др.
Опубликовано: (2018-04-01)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Setiawan, V, и др.
Опубликовано: (2007)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
по: Lund Eiliv, и др.
Опубликовано: (2009-07-01)

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
по: Haiman, C, и др.
Опубликовано: (2011)

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
по: Haiman, C, и др.
Опубликовано: (2007)

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Tsilidis, K, и др.
Опубликовано: (2013)

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
по: Gu, F, и др.
Опубликовано: (2010)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Shui, I, и др.
Опубликовано: (2014)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
по: Shui, I, и др.
Опубликовано: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Lindström, S, и др.
Опубликовано: (2010)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Ahn, J, и др.
Опубликовано: (2009)

Estrogens and breast cancer
по: HANKINSON SUSAN E, и др.
Опубликовано: (1997-01-01)

The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk.
по: Annamaria Pezzotti, и др.
Опубликовано: (2009-01-01)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
по: Machiela, M, и др.
Опубликовано: (2012)

Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort
по: Alexandre Lafourcade, и др.
Опубликовано: (2018-02-01)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
по: Koutros, S, и др.
Опубликовано: (2010)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
по: Travis, R, и др.
Опубликовано: (2009)

Prospective analysis of circulating metabolites and breast cancer in EPIC
по: His, M, и др.
Опубликовано: (2019)

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
по: Siddiq, A, и др.
Опубликовано: (2012)

Response to: Letter by Litwack and DeGruttola regarding “Moral controversies and academic public health: Notes on navigating and surviving academic freedom challenges”
по: Tyler J. VanderWeele
Опубликовано: (2024-12-01)

Moral controversies and academic public health: Notes on navigating and surviving academic freedom challenges
по: Tyler J. VanderWeele
Опубликовано: (2023-12-01)

Viewpoint diversity in public health
по: Tyler J. VanderWeele
Опубликовано: (2023-08-01)

Translation in fragile X: no home runs in the first at-bat
по: Jeremy Veenstra-VanderWeele
Опубликовано: (2017-06-01)

Body mass index and breast cancer survival: a Mendelian randomization analysis
по: Guo, Q, и др.
Опубликовано: (2017)

Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort
по: Cyrille Delpierre, и др.
Опубликовано: (2025-02-01)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Lindström, S, и др.
Опубликовано: (2012)

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
по: Li, K, и др.
Опубликовано: (2018)

Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies
по: Calle, E, и др.
Опубликовано: (1996)

Oral contraceptives and breast cancer. A prospective cohort study.
по: Lipnick, R, и др.
Опубликовано: (1986)

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
по: Kuanrong Li, и др.
Опубликовано: (2018-12-01)

Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort
по: Fortner, RT, и др.
Опубликовано: (2020)